Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-26

Clinical Trial Update: Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures [Phase 1, Phase 2]

View source ↗

Summary

A pharmacokinetic and safety trial of intravenous levetiracetam in neonatal seizures completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Richard H. Haas | Conditions: Seizures, Disorder of Fetus or Newborn | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-26